Transforming Medicines Manufacturing
Innovate UK’s Transforming Medicines Manufacturing programme aims to drive the de-risking and adoption of highly innovative flexible, agile and scalable manufacturing technologies through a culture of collaboration that will drive the growth of this critically important manufacturing sector.
About the programme
The Transforming Medicines Manufacturing (TMM) programme leads on from the ISCF Medicines Manufacturing Challenge Community, which was established in 2017 and ran until 2022, and has been designed to support and grow the UK’s capabilities in manufacturing medicines by developing first-of-a-kind technologies to accelerate patient access to new drugs and treatments.
TMM consists of a range of funding competitions as well as a Community of Practice which will include a range of face-to-face events, interactive workshops and webinars amongst other activities.
Programme objectives
- De-risk the use of technologies in innovative manufacturing.
- Drive disruptive technology innovation of long-term strategic importance.
- Build resilience and growth in the medicines manufacturing sector ensuring health security and patient benefit.
- Support economic recovery and levelling up through supporting job creation, skills development and encouraging inward investment.
- Supporting ambitious ED&I goals across the sector to establish a culture of change.
- Address the Net Zero agenda and sustainability goals through funding novel manufacturing technologies to improve yields reduce waste and cut emissions.
Related programmes
Medicines Manufacturing Skills Investment Programme: The Office for Life Sciences has allocated £6.5m to enhance the UK’s Medicines Manufacturing ecosystem. This funding is being implemented through RESILIENCE, the Medicines Manufacturing Skills Centre of Excellence project, the Industry Skills Accelerator (ISA) in addition to securing the legacy of ATAC (Advanced Therapy Apprenticeship Programme) and ATSTN (Advanced Therapies Skills Training Network). Together, these initiatives aim to support organisations with their skills development and training requirements.
Transforming Medicines Manufacturing introduction
The key to the UK’s future as a global medicines manufacturing hub is its people. The Medicines Manufacturing Challenge has laid the groundwork for building this highly skilled workforce, but we need to continue to nurture the pipeline for the next generation of scientists, engineers and technicians to maintain a thriving industry.
Focus Areas
FOCUS AREA
Nucleic Acid Medicines Manufacturing
Improving the resource efficiency, productivity, and scalability for the manufacture of nucleic acid medicines.
FOCUS AREA
Digitalisation and automation
Driving digitalisation and automation technologies in the development and manufacture of medicines.
FOCUS AREA
Intracellular drug delivery
Development and manufacturing of innovative formulations for DNA and RNA-based medicines.
FOCUS AREA
Flexible, Agile, Sustainable, Scalable Technologies
Investing in advanced manufacturing technologies for better, more responsive manufacturing approaches.
FOCUS AREA
Simplified Delivery of Complex Medicines
Accelerating innovation in complex medicines formulation, manufacturing, and delivery.
The Community of Practice
A collaborative forum, bringing together key stakeholders to drive forward cutting-edge innovation in medicines manufacturing in the UK.
Read more
Related Opportunities
Biomedical Catalyst 2024 Round 1: Industry-led R&D
Opens: 02/09/2024 Closes: 16/10/2024
UK registered SMEs can apply for a share of up to £15 million to develop innovative solutions to health, and healthcare, challenges.
More Information
Sustainable Medicines Manufacturing: Expression of interest
Opens: 14/08/2024 Closes: 16/10/2024
Up to £1 million available for expression of interest (EoI) projects for Grand Challenges in sustainable medicines manufacturing.
More Information
Sustainable Medicines Manufacturing Innovation: Collaborative R&D
Opens: 30/08/2024 Closes: 16/10/2024
Innovate UK and the Department of Health and Social Care (DHSC) will invest up to £15m to support sustainable technologies for medicines manufacturing.
More Information
Canada-UK: Biomanufacturing of Biologics and Advanced Therapies Round 2
Opens: 08/05/2024 Closes: 16/10/2024
UK registered organisations can apply for a share of up to £3m for collaboration with Canadian SMEs in biomanufacturing of biologics and advanced therapies.
More Information
PACE: 2024 Diagnostic Innovations
Opens: 26/09/2024 Closes: 30/10/2024
PACE (Pathways to Antimicrobial Clinical Efficacy) aims to accelerate early-stage translational innovation to tackle antimicrobial resistance (AMR).
More Information
BBSRC ICURe engage November 2024: London & S/SE England
Opens: 23/09/2024 Closes: 21/10/2024
ICURe engage is a 4-week, part-time entrepreneurship programme tailored for bioscience research students and technicians.
More Information
Join the community
Join the medicines manufacturing community of practice to stay up to date with the latest news, grant funding, policy changes and regulatory announcements. Interact and collaborate with other organisations and help shape the future of medicines manufacturing in the UK.